Antonio R. Montaño
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Antonio R. Montaño has a total of 20 co-authors. Here are the top co-authors by number of shared publications:
- Lei G. Wang
Department Biomedical Engineering Oregon Health & Science University Portland Oregon 97201 USA
3 shared publications - Summer L. Gibbs
Department of Biomedical Engineering, Oregon Health & Science University, Portland, OR 97201, USA
3 shared publications Allison Solanki
Biomedical Engineering Department, Oregon Health & Science University, Portland, USA
2 shared publications- Dani A. Szafran
Biomedical Engineering Department, Oregon Health & Science University, Portland, OR 97201, USA
2 shared publications Jason R. Combs
Biomedical Engineering Department, Oregon Health & Science University, Portland, USA
2 shared publicationsKai Tao
Cancer Early Detection Advanced Research Center (CEDAR), Oregon Health & Science University, Portland, USA
2 shared publications
Latest Publications
- Open Access
- 28 April 2023
- Published by Springer Nature in Nature Chemistry
- Vol. 15 (5) , 740
Publisher Correction: OregonFluor enables quantitative intracellular paired agent imaging to assess drug target availability in live cells and tissues
- 28 April 2023
- Published by Springer Nature in Nature Chemistry
- Vol. 15 (5) , 740
Open AccessPublisher Correction: OregonFluor enables quantitative intracellular paired agent imaging to assess drug target availability in live cells and tissues
- 30 March 2023
- Published by Springer Nature in Nature Chemistry
- Vol. 15 (5) , 729-739
OregonFluor enables quantitative intracellular paired agent imaging to assess drug target availability in live cells and tissues
Non-destructive fluorophore diffusion across cell membranes to provide an unbiased fluorescence intensity readout is critical for quantitative imaging applications in live cells and tissues. Commercially available small-molecule fluorophores have been engineered for biological compatibility, imparting high water solubility by modifying rhodamine and cyanine dye scaffolds with multiple sulfonate groups. The resulting net negative charge, however, often renders these fluorophores cell-membrane-impermeant. Here we report the design and development of our biologically compatible, water-soluble and cell-membrane-permeable fluorophores, termed OregonFluor (ORFluor). By adapting previously established ratiometric imaging methodology using bio-affinity agents, it is now possible to use small-molecule ORFluor-labelled therapeutic inhibitors to quantitatively visualize their intracellular distribution and protein target-specific binding, providing a chemical toolkit for quantifying drug target availability in live cells and tissues.
- 30 March 2023
- Published by Springer Nature in Nature Chemistry
- Vol. 15 (5) , 729-739
OregonFluor enables quantitative intracellular paired agent imaging to assess drug target availability in live cells and tissues
Non-destructive fluorophore diffusion across cell membranes to provide an unbiased fluorescence intensity readout is critical for quantitative imaging applications in live cells and tissues. Commercially available small-molecule fluorophores have been engineered for biological compatibility, imparting high water solubility by modifying rhodamine and cyanine dye scaffolds with multiple sulfonate groups. The resulting net negative charge, however, often renders these fluorophores cell-membrane-impermeant. Here we report the design and development of our biologically compatible, water-soluble and cell-membrane-permeable fluorophores, termed OregonFluor (ORFluor). By adapting previously established ratiometric imaging methodology using bio-affinity agents, it is now possible to use small-molecule ORFluor-labelled therapeutic inhibitors to quantitatively visualize their intracellular distribution and protein target-specific binding, providing a chemical toolkit for quantifying drug target availability in live cells and tissues.
- 6 May 2020
- Published by American Association for the Advancement of Science (AAAS) in Science Translational Medicine
- Vol. 12 (542)
Near-infrared nerve-binding fluorophores for buried nerve tissue imaging
Small-molecule near-infrared nerve contrast agents were developed to enable nerve visualization at depth, improving nerve-sparing during surgery.
- 6 May 2020
- Published by American Association for the Advancement of Science (AAAS) in Science Translational Medicine
- Vol. 12 (542)
Near-infrared nerve-binding fluorophores for buried nerve tissue imaging
Small-molecule near-infrared nerve contrast agents were developed to enable nerve visualization at depth, improving nerve-sparing during surgery.